BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18852410)

  • 1. Notice of duplicate publication: "Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis" (arch intern med. 2008;168[2]:235-236).
    Shariat SF; Roehrborn CG; Lamb DJ; Slawin KM
    Arch Intern Med; 2008 Oct; 168(18):2046-7. PubMed ID: 18852410
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis.
    Shariat SF; Lamb DJ; Roehrborn CG; Slawin KM
    Arch Intern Med; 2008 Jan; 168(2):235-6. PubMed ID: 18227373
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
    Halland A; Jønler M; Pedersen KV
    Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring androgen replacement therapy: testosterone and prostate safety.
    Morales A
    J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone may speed up the growth of prostate cancer due to aromatase activity.
    Friedman AE
    BJU Int; 2010 Aug; 106(3):434. PubMed ID: 20653657
    [No Abstract]   [Full Text] [Related]  

  • 6. Testosterone deficiency, supplementation, and prostate cancer: maintaining a balanced perspective.
    Trost LW; Hellstrom WJ
    J Sex Med; 2013 Dec; 10(12):2879-81. PubMed ID: 24299509
    [No Abstract]   [Full Text] [Related]  

  • 7. 54-year-old man with breast cancer after prolonged testosterone therapy.
    Sorscher S
    Clin Adv Hematol Oncol; 2005 Sep; 3(9):713. PubMed ID: 16224445
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone therapy in castrate-resistant prostate cancer: a possible new approach.
    Gardiner RA; Sweeney C; Tilley WD
    Eur Urol; 2009 Aug; 56(2):245-6. PubMed ID: 19409691
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer drugs could pose risk to heart health. FDA reviewing safety of anti-hormone treatments due to links with heart disease and diabetes.
    Heart Advis; 2010 Aug; 13(8):5. PubMed ID: 22792575
    [No Abstract]   [Full Text] [Related]  

  • 11. Reproductive endocrinology: Are intramuscular testosterone injections harmful?
    Anawalt BD; Bremner WJ
    Nat Rev Endocrinol; 2015 Sep; 11(9):510-1. PubMed ID: 26149613
    [No Abstract]   [Full Text] [Related]  

  • 12. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
    Van Patten CL; de Boer JG; Tomlinson Guns ES
    J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing prostate cancer.
    Gillmore R
    Practitioner; 2004 Apr; 248(1657):274-80. PubMed ID: 15114817
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate cancer: altering the natural history by dietary changes.
    Srivastava AR; Dalela D
    Natl Med J India; 2004; 17(5):248-53. PubMed ID: 15638305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioidentical testosterone cream: a rare cause of postmenopausal virilisation.
    Ogilvie CM; Levenberg R; Milsom SR
    Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):116-7. PubMed ID: 19281592
    [No Abstract]   [Full Text] [Related]  

  • 16. [Androgen deficiency in males and its correction in respect to pathogenesis of prostatic cancer].
    Mazo EB; Grigor'ev ME; Konorev VA; Ermisheva OM
    Urologiia; 2008; (3):57-8, 60-2. PubMed ID: 18669351
    [No Abstract]   [Full Text] [Related]  

  • 17. Misinterpretation of the Comparative Safety of Testosterone Dosage Forms-Reply.
    Layton JB; Stürmer T; Brookhart MA
    JAMA Intern Med; 2015 Nov; 175(11):1875-6. PubMed ID: 26524762
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connubial androgenetic alopecia.
    Lattouf C; Miteva M; Tosti A
    Arch Dermatol; 2011 Nov; 147(11):1329-30. PubMed ID: 22106127
    [No Abstract]   [Full Text] [Related]  

  • 20. Misinterpretation of the Comparative Safety of Testosterone Dosage Forms.
    Schooling CM
    JAMA Intern Med; 2015 Nov; 175(11):1874-5. PubMed ID: 26524760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.